wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34105064-1EC185C4-0521-4BF7-9EA7-D92663350D4C
Q34105064-1EC185C4-0521-4BF7-9EA7-D92663350D4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34105064-1EC185C4-0521-4BF7-9EA7-D92663350D4C
Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.
P2860
Q34105064-1EC185C4-0521-4BF7-9EA7-D92663350D4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34105064-1EC185C4-0521-4BF7-9EA7-D92663350D4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1ebed8a8d9c8109ec4d01f80f756a02f5e5bd9c3
P2860
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.